|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 26375 |
FusionGeneSummary for PDE1C_LAT2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PDE1C_LAT2 | Fusion gene ID: 26375 | Hgene | Tgene | Gene symbol | PDE1C | LAT2 | Gene ID | 5137 | 23428 |
| Gene name | phosphodiesterase 1C | solute carrier family 7 member 8 | |
| Synonyms | Hcam3|cam-PDE 1C|hCam-3 | LAT2|LPI-PC1 | |
| Cytomap | 7p14.3 | 14q11.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CHuman 3',5' cyclic nucleotide phosphodiesterase (HSPDE1C1A)phosphodiesterase 1C, calmodulin-dependent 70kDa | large neutral amino acids transporter small subunit 2L-type amino acid transporter 2integral membrane protein E16Hsolute carrier family 7 (amino acid transporter light chain, L system), member 8solute carrier family 7 (amino acid transporter, L-type), | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q14123 | Q9GZY6 | |
| Ensembl transtripts involved in fusion gene | ENST00000396193, ENST00000396191, ENST00000321453, ENST00000396184, ENST00000479980, ENST00000396182, | ENST00000344995, ENST00000460943, ENST00000398475, ENST00000275635, | |
| Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 1 X 1 X 1=1 |
| # samples | 3 | 1 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: PDE1C [Title/Abstract] AND LAT2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | LAT2 | GO:0006865 | amino acid transport | 10391915|10574970|15918515 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AV724221 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000396193 | ENST00000344995 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396193 | ENST00000460943 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-intron | ENST00000396193 | ENST00000398475 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396193 | ENST00000275635 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396191 | ENST00000344995 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396191 | ENST00000460943 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-intron | ENST00000396191 | ENST00000398475 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396191 | ENST00000275635 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000321453 | ENST00000344995 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000321453 | ENST00000460943 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-intron | ENST00000321453 | ENST00000398475 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000321453 | ENST00000275635 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396184 | ENST00000344995 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396184 | ENST00000460943 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-intron | ENST00000396184 | ENST00000398475 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396184 | ENST00000275635 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000479980 | ENST00000344995 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000479980 | ENST00000460943 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-intron | ENST00000479980 | ENST00000398475 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000479980 | ENST00000275635 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396182 | ENST00000344995 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396182 | ENST00000460943 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-intron | ENST00000396182 | ENST00000398475 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
| intron-3UTR | ENST00000396182 | ENST00000275635 | PDE1C | chr7 | 32088724 | - | LAT2 | chr7 | 73643778 | + |
Top |
FusionProtFeatures for PDE1C_LAT2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PDE1C | LAT2 |
| Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are keyregulators of many important physiological processes. Has a highaffinity for both cAMP and cGMP. | Involved in FCER1 (high affinity immunoglobulin epsilonreceptor)-mediated signaling in mast cells. May also be involvedin BCR (B-cell antigen receptor)-mediated signaling in B-cells andFCGR1 (high affinity immunoglobulin gamma Fc receptor I)-mediatedsignaling in myeloid cells. Couples activation of these receptorsand their associated kinases with distal intracellular eventsthrough the recruitment of GRB2. {ECO:0000269|PubMed:12486104,ECO:0000269|PubMed:12514734, ECO:0000269|PubMed:15010370}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PDE1C_LAT2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PDE1C_LAT2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PDE1C_LAT2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PDE1C_LAT2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | PDE1C | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|